|
Volumn 58, Issue 9, 2010, Pages 1136-1141
|
Nateglinide controlled release tablet containing compressionable enteric coated granules
|
Author keywords
Compressionable enteric coated granule; Nateglinide; Repeated administration
|
Indexed keywords
EUDRAGIT;
GLICLAZIDE;
GLUCOSE;
NATEGLINIDE;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED RELEASE FORMULATION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DESIGN;
DRUG EFFECT;
DRUG SOLUBILITY;
DRUG STRUCTURE;
ENTERIC COATED TABLET;
EXPERIMENTAL DOG;
GLUCOSE BLOOD LEVEL;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NONHUMAN;
PH MEASUREMENT;
TABLET COMPRESSION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ADMINISTRATION, ORAL;
ANIMALS;
BLOOD GLUCOSE;
CYCLOHEXANES;
DELAYED-ACTION PREPARATIONS;
DOGS;
HYPOGLYCEMIC AGENTS;
MALE;
PHENYLALANINE;
SOLUBILITY;
TABLETS, ENTERIC-COATED;
|
EID: 77956317175
PISSN: 00092363
EISSN: 13475223
Source Type: Journal
DOI: 10.1248/cpb.58.1136 Document Type: Article |
Times cited : (12)
|
References (15)
|